Human-Derived Biological Products
Whole Blood
Description
Customized Projects
Disease State
ProductsPacking & Shipping
Donor Criteria
Whole blood is human blood from a standard blood donation. The blood is typically combined with an anticoagulant during the collection process, but is generally otherwise unprocessed; whole blood can be separated into red blood cells, platelets, and plasma.
If possible, HemaCare will utilize any commercially available anticoagulant per your specifications:
ACA
ACD
Citrate Phosphate Dextrose
CPD
CPDA-1
CTAD
EDTA (Potassium)
EDTA (Sodium Fluoride) EDTA (Sodium)
Heparin (Lithium)
Heparin (Sodium)
K2 EDTA
K3 EDTA
Lithium Heparin
Phosphoric Acid
Potassium Oxalate Sodium Citrate
Sodium EDTA
Sodium Fluoride
Sodium Fluoride/Potassium Oxalate
Sodium Heparin
HemaCare has the capability to prepare and provide whole blood according to your specifications:
- Specialized research donor subject recruitment
- Customized collections
HemaCare can source disease state material from donors with autoimmune disorders, infectious diseases, or certain rare disorders (among others). Some examples of disease states include:
- Celiac Disease
- Crohn's disease
- Lupus (SLE)
- Psoriasis
- Rheumatoid Arthritis
- Rheumatoid Factor (RF)
- HIV, HPV, HBV & HCV positive donors
If you don't see a product you are looking for, contact us! (877) 397-3087.
Packaging and shipping specifications play an important role in maintaining the quality of your product. We package and ship all products to your specifications.
Whole blood is typically packaged and shipped overnight on the day of collection. Unless instructed otherwise, platelets are packaged to maintain a temperature between 1 and 10°C during shipment.
Temperature monitoring data tracking devices are available for use at your request.
Our healthy donor subjects for research products are screened with the same stringent regulations and requirements as donors who donate transfusable blood components.
Donors must:
- Be at least 18 years old.
- Weigh at least 140 lbs.
- Be in good health and feeling well.
- Not be pregnant.
- Meet protocol specifications, i.e. CBC lab tests.
- Be prescreened for evidence of transmissible infectious diseases (HIV, Hepatitis B, and Hepatitis C) before donation. This panel of tests is repeated with each product collection.
- Have adequate peripheral veins for apheresis.
- Complete and sign a Donor History Questionnaire developed by the AABB and accepted by the FDA and a procedure-specific consent form prior to the collection procedure. All consents and protocols have been approved by an independent biomedical review board (IRB).